Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02446951 · ClinicalTrials.gov registry record
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
A clinical trial, sponsored by Children's Hospitals and Clinics of Minnesota.
- Completed
- Registry status
- 925
- Enrollment target
NCT02446951 is a clinical trial that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 925 participants.
The verdict
NCT02446951 has completed, sponsored by Children's Hospitals and Clinics of Minnesota.
- COMPLETED
- Registry status
- 925 participants
- Enrollment target
Study Summary
Jaundice is a condition caused by elevated levels of bilirubin in the body otherwise known as hyperbilirubinemia. It occurs when there is an increase in bilirubin production or normal production with problems eliminating it from the body. Serum levels of bilirubin in excess of 5 mg/dL signifies clinical jaundice, yet more than half of full term infants experience these levels within the first week of life. For those patients who have markedly elevated serum bilirubin levels, which phototherapy cannot sufficiently treat, the use of exchange transfusions is a viable option within the hospital setting. In comparison, bili-blankets have been used as a form of phototherapy for those patients being treated in a home-based setting to reduce the likelihood of hospital readmissions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 925 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02446951
The ClinicalTrials.gov registry entry for NCT02446951 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 925 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02446951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02446951 about?
NCT02446951 is a clinical study titled "Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department". Jaundice is a condition caused by elevated levels of bilirubin in the body otherwise known as hyperbilirubinemia. It occurs when there is an increase in bilirubin production or normal production with problems eliminating it from the body. Serum levels of bilirubin in excess of 5 mg/dL signifies clin...
What is the current status of trial NCT02446951?
This trial is currently completed. The enrollment target is 925 participants. The study started on 2015-01. Estimated completion is 2016-12-31.
Who is sponsoring clinical trial NCT02446951?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.